Publication:
Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results From an Open-Label Multicenter Clinical Trial in Previously Untreated Patients With Severe Hemophilia A

dc.authorwosidPeyvandi, Flora/Aak-7437-2020
dc.contributor.authorSidonio, Robert F., Jr.
dc.contributor.authorThompson, Alexis A.
dc.contributor.authorPeyvandi, Flora
dc.contributor.authorAlbayrak, Canan
dc.contributor.authorYeoh, Seoh Leng
dc.contributor.authorLam, Joyce
dc.contributor.authorTanada, Srillatha
dc.date.accessioned2025-12-11T00:40:30Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Sidonio, Robert F., Jr.] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA; [Thompson, Alexis A.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Peyvandi, Flora] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Peyvandi, Flora] Univ Studi Milano, Dept Pathophysiol & Transplantat, Milan, Italy; [Albayrak, Canan] Ondokuz Mayis Univ, Dept Pediat Hematol, Samsun, Turkey; [Yeoh, Seoh Leng] Hosp Pulau Pinang, Dept Pediat, George Town, Penang, Malaysia; [Lam, Joyce] KK Womens & Childrens Hosp, Singapore, Singapore; [Maggiore, Caterina] IQVIA, Milan, Italy; [Engl, Werner] Takeda Co, Baxalta Innovat GmbH, Vienna, Austria; [Allen, Geoffrey; Tanada, Srillatha] Takeda Dev Ctr Amer Inc, Cambridge, MA USAen_US
dc.description.woscitationindexScience Citation Index Expanded - Conference Proceedings Citation Index - Science
dc.identifier.doi10.1182/blood-2021-146143
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1182/blood-2021-146143
dc.identifier.urihttps://hdl.handle.net/20.500.12712/38354
dc.identifier.volume138en_US
dc.identifier.wosWOS:000736413905006
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleRurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results From an Open-Label Multicenter Clinical Trial in Previously Untreated Patients With Severe Hemophilia Aen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files